Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.94 is 10% below its 5-year average of -1.76, around the middle of its 5-year range (-2.24–-1.37).
11.82% below its 12-month average of -1.73.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.47.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.94
EARNINGS PER SHARE (EPS) AVG TTM
-1.73
EARNINGS PER SHARE (EPS) AVG 3Y
-1.92
EARNINGS PER SHARE (EPS) AVG 5Y
-1.76
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.82%
CURRENT VS 3Y AVG
-1.17%
CURRENT VS 5Y AVG
-10.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PROCEPT BioRobotics Corporation
Market Cap
$988.11M
Earnings Per Share (EPS)
-1.94
TTM Avg
-1.73
3Y Avg
-1.92
5Y Avg
-1.76
Market Cap
$991.32M
Earnings Per Share (EPS)
0.71
TTM Avg
-1.77
3Y Avg
-1.98
5Y Avg
-1.86
Market Cap
$986.83M
Earnings Per Share (EPS)
-1.05
TTM Avg
-1.23
3Y Avg
-0.94
5Y Avg
-0.94
Market Cap
$983.56M
Earnings Per Share (EPS)
0.35
TTM Avg
-0.99
3Y Avg
-0.18
5Y Avg
0.61
Market Cap
$997.66M
Earnings Per Share (EPS)
-2.97
TTM Avg
-9.41
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$1.00B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.83
3Y Avg
-0.98
5Y Avg
-0.98
Market Cap
$950.37M
Earnings Per Share (EPS)
-3.37
TTM Avg
-2.60
3Y Avg
-2.33
5Y Avg
-2.16
Market Cap
$942.94M
Earnings Per Share (EPS)
-3.85
TTM Avg
-2.71
3Y Avg
-1.96
5Y Avg
-1.55
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $988.11M | -1.94 | -1.73 | -1.92 | -1.76 |
| MeiraGTx Holdings plc (MGTX)vs › | $991.32M | 0.71 | -1.77 | -1.98 | -1.86 |
| Aktis Oncology, Inc. (AKTS)vs › | $986.83M | -1.05 | -1.23 | -0.94 | -0.94 |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.56M | 0.35 | -0.99 | -0.18 | 0.61 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $997.66M | -2.97 | -9.41 | -6.16 | -6.16 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -0.38 | -0.83 | -0.98 | -0.98 |
| Kura Oncology, Inc. (KURA)vs › | $950.37M | -3.37 | -2.60 | -2.33 | -2.16 |
| MoonLake Immunotherapeutics (MLTX)vs › | $942.94M | -3.85 | -2.71 | -1.96 | -1.55 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | -0.09 | -3.41 | -0.94 | -0.03 |
Trailing EPS (TTM)
$-1.94
Forward EPS (Est.)
$-1.67
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.72 |
| 2024-12-31 | -1.75 |
| 2023-12-31 | -2.24 |
| 2022-12-31 | -1.96 |
| 2021-12-31 | -1.37 |
| 2020-12-31 | -1.51 |
| 2019-12-31 | -1.25 |
